Stockreport

Rising fears of needlestick injuries and preference for painless options propel the needle-free injection system market towards a US$ 667 million valuation by 2034 | FMI Study [Yahoo! Fina...

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF The increasing preference for minimally invasive biopsies drives the growth of the needle-free injection systems market NEWARK, Del, March 04, 2024 (GLOBE NEWSWIRE) -- [Read more]